CD19 Antikörper
(1 reference)-
- Target Alle CD19 Antikörper anzeigen
- CD19 (CD19 Molecule (CD19))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD19 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of human CD19 expressed in E. coli.
- Klon
- 2E2B6B10
- Isotyp
- IgG2b
- Top Product
- Discover our top product CD19 Primärantikörper
-
anti-CD19 Molecule (CD19) (AA 485-556) antibody
CD19 Reaktivität: Human, Maus, Ratte, Schaf FACS, ELISA, IHC (fro), IHC (p), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 151-250) antibodyCD19 Reaktivität: Human, Maus, Ratte FACS, WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 20-291) antibodyCD19 Reaktivität: Human FACS, WB, IF, IHC, ELISA Wirt: Maus Monoclonal 8G11B7 unconjugated
anti-CD19 Molecule (CD19) (C-Term) antibodyCD19 Reaktivität: Human, Maus, Affe, Ratte, Schaf, Schwein, Rind (Kuh), Meerschweinchen, Hund, Esel, Ziege, Hamster, Pferd, Kaninchen, Avian, Cat, Huhn WB Wirt: Ziege Polyclonal unconjugated
anti-CD19 Molecule (CD19) (pTyr531) antibodyCD19 Reaktivität: Human, Maus FACS, ELISA, IHC (fro), IHC (p), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) antibodyCD19 Reaktivität: Human FACS, WB, IF, ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 96-281) antibodyCD19 Reaktivität: Human FACS, IHC, ELISA, Coat, StM Wirt: Maus Monoclonal CD19-3116 unconjugated
anti-CD19 Molecule (CD19) (AA 143-172) antibodyCD19 Reaktivität: Human FACS, WB, IF, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) (AA 160-258) antibodyCD19 Reaktivität: Human WB, IP, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-CD19 Molecule (CD19) antibodyCD19 Reaktivität: Human FACS, IP Wirt: Maus Monoclonal LT19 unconjugated
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
-
: "Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies." in: Leukemia research, Vol. 12, Issue 2, pp. 135-41, (1988) (PubMed).
-
: "Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies." in: Leukemia research, Vol. 12, Issue 2, pp. 135-41, (1988) (PubMed).
-
- Target
- CD19 (CD19 Molecule (CD19))
- Andere Bezeichnung
- CD19 (CD19 Produkte)
- Synonyme
- B4 antikoerper, CVID3 antikoerper, AW495831 antikoerper, CD19 antikoerper, CD19 molecule antikoerper, CD19 antigen antikoerper, CD19 antikoerper, Cd19 antikoerper
- Hintergrund
-
Description: The CD19 antigen (95 kDa) is expressed from the earliest stage of B progenitor development, on all , peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia , tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation , to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition , will influence B cell activation and proliferation.
Aliases: B4, MGC12802
- Gen-ID
- 930
- HGNC
- 930
- Pathways
- Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung
-
